Junli He
Junli He has made 1 open-market purchase worth $394k since Sep 25, 2026, in 1 company. The latest: $394k of HRGN, filed Sep 25, 2026, scored 32 out of 100.
CEO, Harvard Apparatus Regenerative Technology, Inc.
Follow Junli He, freeOpen the live feed
A free account gets an alert the minute a new buy or sale is filed.
Purchases
| Filed | Stock | Stake | Score | Bought | 1 week | 1 month |
|---|---|---|---|---|---|---|
| Sep 25 Form 4 (opens sec.gov) |
HRGNHarvard Apparatus Regenerative Technology, Inc. · CEOCEO · Near 52-week low · Filed late · Penny stock: hard to trade | +38% stake | 32 | $394k 368,630 at $1.07 |
+11.2% | −0.4% |
Track record (hypothetical): a week after the filing, these buys averaged +11.2% (100% up, 1 measured); a month after, −0.4% (0% up, 1 measured).
Questions
What stock has Junli He bought?
HRGN (Harvard Apparatus Regenerative Technology, Inc.), all on the open market and reported on SEC Form 4.
When did Junli He last buy?
Sep 25, 2026: 368,630 shares of HRGN at $1.07, $394k in all (Form 4 (opens sec.gov)).
Has Junli He filed a notice of a planned sale?
Not in the filings on record. A Form 144 is the notice an insider must file before selling restricted or control shares, and it lands on EDGAR before the sale is reported.
Is Junli He a routine or an opportunistic buyer?
There isn't enough history to say yet.
Data as of Sep 25, 2026, from SEC EDGAR Form 4 filings: open-market purchases (code P) of $25,000 or more, and open-market sales. Every row links to its filing. Scores summarise what a filing says (how the score works); outcomes are hypothetical, from the first close after the filing, and past results don't predict future ones. Disclaimer